microbi
infect
lead
caus
death
around
world
infecti
diseas
caus
drugresist
microb
may
lead
delay
administr
microbiolog
effect
therapi
chen
et
al
del
chierico
et
al
therefor
exhaust
understand
microbi
physiolog
infect
defens
system
surviv
strategi
great
interest
order
activ
defeat
microbi
infect
microbi
proteom
provid
complet
inform
microbi
physiolog
express
function
protein
involv
infect
also
give
clue
clinic
diagnosi
antimicrobi
therapi
bou
vranaki
et
al
microbi
proteom
help
identifi
protein
associ
microbi
activ
microbi
hostpathogen
interact
antimicrobi
resist
mechan
microbi
activ
pathogen
confirm
use
gelbas
gelfre
method
combin
malditoflcmsm
proteom
analysi
microbi
hostpathogen
interact
reveal
valuabl
inform
virul
pathogen
resist
help
better
understand
infect
develop
strategi
microbi
infect
cheng
et
al
fig
schemat
illustr
proteom
analysi
bacteri
sampl
proteom
studi
microbi
pathogen
provid
invalu
inform
interact
host
pathogen
captur
clear
understand
infecti
process
identifi
protein
express
pathogen
infect
walter
mobley
pathogen
affect
variou
molecul
adhes
invas
host
cell
infect
neighbor
cell
spread
host
system
circul
evas
host
defens
mechan
proteom
profil
provid
new
insight
virul
protein
like
proteoglycan
mediat
hostpathogen
interact
affect
invas
progress
outcom
infect
hostpathogen
interact
microb
affect
posttransl
modif
like
phosphoryl
glycosyl
acetyl
rapidli
identifi
ms
jean
beltran
et
al
ravikumar
et
al
mani
proteom
techniqu
use
studi
hostpathogen
interact
may
lead
discoveri
import
biolog
insight
differ
kind
method
avail
fig
shotgun
proteom
analysi
bacteri
sampl
isol
protein
bacteria
purif
isol
protein
sampl
separ
protein
base
isoelectr
point
molecular
weight
express
proteinth
new
protein
digest
trypsin
sampl
mix
suitabl
matrix
maldi
analysisand
identif
protein
sequenc
databas
detect
hostpathogen
interact
yeast
hybrid
affin
purificationmass
spectrometri
chemic
crosslink
mass
spectrometri
proximitydepend
label
strategiesmass
spectrometri
protein
microarraybas
technolog
protein
correl
profil
advantag
disadvantag
tabl
nicod
et
al
viral
bacteri
protein
interact
host
hub
protein
central
protein
alter
cellular
process
viral
pathogen
seem
unavoid
disturb
cellular
process
reli
transcript
machineri
wherea
bacteria
tend
mesh
immun
respons
prevent
clearanc
also
manipul
host
ubiquitin
pathway
virus
bacteri
effector
protein
recurr
find
control
protein
degrad
cell
signal
ubiquitin
critic
regul
variou
cellular
process
inflammatori
respons
vesicular
traffick
cell
cycl
altogeth
make
ideal
target
hijack
bacteri
viral
pathogen
martinezmartin
yang
et
al
infectioninvolv
protein
inevit
contribut
elucid
path
physiolog
pathogenhost
interact
tabl
give
overview
main
advantag
disadvantag
commonli
use
hostpathogen
proteinprotein
interact
hpppi
detect
method
microbi
infect
common
caus
diseas
develop
caus
million
death
around
world
recurr
antibiot
resist
microbi
infect
demand
advanc
techniqu
medic
diagnost
field
time
diagnosi
effect
approach
prevent
diseas
requir
accur
fast
identif
character
infect
pathogen
bacteria
fungi
virus
parasit
new
develop
diagnost
techniqu
identif
purpos
also
illumin
bacteri
infect
mechan
bacteri
adapt
human
host
input
help
discoveri
new
therapeut
approach
control
erad
microbialassoci
infect
clinic
diagnosi
microb
base
cultur
solid
media
molecular
new
emerg
techniqu
culturebas
diagnosi
clinic
sampl
solid
select
enrich
medium
sensit
easili
contamin
labordepend
timeconsum
process
chanc
error
occur
diagnosi
report
current
autom
identif
system
give
reliabl
result
shorter
period
time
also
antimicrobi
suscept
test
van
belkum
et
al
molecular
method
accur
specif
sensit
faster
tradit
culturebas
method
use
stabl
genotyp
characterist
revers
phenotyp
characterist
molecular
method
two
type
immunolog
nucleic
acidbas
techniqu
immunolog
techniqu
base
bind
diagnost
antibodi
specif
antigen
determin
target
human
bodi
produc
specif
antibodi
respons
microbi
infect
possibl
use
antibodi
detect
acut
past
infect
elisa
commonli
use
techniqu
clinic
diagnosi
due
speed
capac
easi
handl
rel
low
cost
molecular
method
also
limit
due
difficulti
gener
select
antibodi
requir
larg
amount
respect
antigen
quantifi
bacteria
develop
antibodi
requir
degre
specif
difficult
complex
organ
gehr
et
al
mangal
et
al
nucleic
acid
techniqu
dnaand
rnabas
techniqu
dnabas
techniqu
includ
dna
microarray
pcrand
rnabas
techniqu
rtpcr
tma
pcr
one
greatest
invent
discov
kari
bank
mulli
provid
great
improv
microbi
diagnosi
use
speciesspecif
sequenc
detect
identifi
pathogen
requir
predict
speci
presenc
clinic
sampl
limit
pcr
techniqu
follow
limit
number
pcr
assay
perform
per
clinic
sampl
infect
diseas
monocultur
frequent
caus
speciesspeci
interact
even
strainstrain
interact
requir
proper
standard
control
valid
interpret
maurer
nucleic
acidbas
technolog
work
base
entir
dna
presenc
extracellular
dna
might
influenc
dnabas
signal
detect
signific
amount
extracellular
dna
releas
bacteri
cell
destroy
immun
defens
detect
therefor
dnabas
signal
obtain
diagnosi
influenc
presenc
extracellular
dna
might
lead
misidentif
maurer
clinic
diagnosi
requir
rapid
reliabl
costeffect
method
identif
potenti
pathogen
clinic
sampl
appropri
antimicrobi
therapi
may
initi
earli
malditof
ms
use
earli
identif
bacteria
blood
urinari
tract
infect
clinic
sampl
msbase
proteom
approach
use
clinic
diagnost
procedur
includ
character
identif
classif
microorgan
matrixassist
laser
desorptionion
timeofflight
ms
malditof
ms
broadli
adopt
mani
clinic
microbiolog
laboratori
past
decad
chen
et
al
malditof
ms
emerg
tool
use
identifi
microorgan
speci
level
even
strain
differenti
base
molecular
signatur
wieser
et
al
success
implement
techniqu
routin
laboratori
due
fast
easi
highthroughput
characterist
moreov
gener
simpl
easili
interpret
spectra
bacteri
identif
malditof
ms
process
involv
differ
step
ie
protein
separ
gel
analysi
gel
digest
analysi
sampl
mix
suitabl
matrix
target
plate
today
sampl
expos
short
laser
puls
laser
energi
vapor
protein
sampl
lead
ioniz
ion
reach
detector
timeofflight
tof
tube
base
tof
inform
characterist
spectrum
record
constitut
specif
sampl
fingerprint
uniqu
given
speci
increas
mass
ion
charg
ratio
mz
correspond
lower
speed
longer
time
need
reach
detector
tracz
et
al
malditof
ms
reproduc
reliabl
tool
microbi
identif
identifi
bacteri
isol
minut
low
cost
high
effici
diagnost
costperanalysi
point
view
singhal
et
al
proteom
provid
valuabl
data
field
microbiolog
proteom
character
molecular
model
system
investig
specif
aspect
microbiolog
gene
express
metabol
medic
microbiolog
data
help
analyz
diseas
mechan
pathogen
interact
host
investig
larg
focus
develop
novel
approach
treatment
prevent
infecti
diseas
herschend
et
al
wang
et
al
proteom
tool
use
differ
way
diagnos
diseas
proteom
tactic
use
improv
screen
earli
detect
cancer
attain
identifi
protein
whose
express
affect
diseas
process
individu
protein
call
biomark
wherea
set
protein
alter
express
level
call
protein
signatur
kim
hwang
kuppusami
et
al
appli
proteom
technolog
may
improv
understand
diseas
process
develop
new
biomark
diagnosi
earli
detect
diseas
acceler
drug
develop
emerg
techniqu
creat
numer
opportun
challeng
meet
need
high
sensit
high
throughput
requir
diseaserel
probe
gregorich
ge
mehan
et
al
biomark
use
candid
earli
screen
detect
cancer
vitro
estim
two
patholog
protein
ag
proteom
technolog
high
sensit
method
diagnos
tuberculosi
clinic
isol
geyer
et
al
thoma
et
al
pathogenesi
sever
acut
respiratori
syndrom
sar
well
unstat
specif
diagnost
method
critic
manag
control
diseas
proteom
analysi
sera
patient
sar
identifi
potenti
protein
marker
shorten
antitrypsin
consist
found
higher
concentr
sera
sar
patient
relat
healthi
control
marker
may
use
diagnost
tool
therapeut
potenti
vaccin
target
clay
et
al
mcbride
field
proteom
also
use
identifi
differenti
express
cancer
cell
may
reflect
differ
insensit
tendenc
develop
resist
treatment
mohammad
et
al
proteom
identifi
protein
involv
metastasi
multidrug
resist
highli
express
glioblastoma
multiform
compar
brain
tissu
protein
potenti
diagnost
drug
resist
invas
marker
glioblastoma
tumor
drug
resist
major
clinic
problem
treatment
mani
infecti
diseas
chowdhuri
et
al
hanif
et
al
olar
aldap
proteom
show
solut
drug
develop
resist
chloroquin
success
drug
treat
malaria
reduc
almost
ineffect
mani
part
world
widespread
emerg
chloroquin
resist
help
proteom
technolog
potenti
therapeut
target
hostpathogen
interact
proteindrug
interact
plasmodium
speci
identifi
bhattacharyya
chakrabarti
hossain
et
al
suazo
et
al
clinic
microbiolog
combin
malditof
ms
play
key
role
bacteri
identif
suscept
test
nucleic
acid
target
facilit
better
workflow
time
manag
posit
blood
cultur
sampl
detect
proteom
chang
resist
versu
suscept
bacteri
speci
perform
classic
malditof
ms
mode
rahi
et
al
identif
character
bacteri
isol
patient
within
transient
period
diagnosi
reduc
morbid
mortal
valu
earli
detect
key
success
treatment
diseas
clinic
test
result
base
chemic
composit
man
power
chanc
falseerror
occur
late
time
reduc
error
improv
experiment
design
improv
outcom
sung
et
al
msbase
biomark
technolog
enabl
earli
detect
cancer
cardiovascular
diseas
field
biomark
research
mainli
focus
genom
transcriptom
proteom
understand
gene
regul
function
involv
diseas
develop
expect
ideal
msbase
biomark
reflect
signific
recent
futur
improv
technolog
basi
crutchfield
et
al
fig
illustr
research
area
medic
microbiolog
util
proteom
technolog
normal
method
identif
bacteria
base
phenotyp
characterist
biochem
reaction
method
achiev
high
accuraci
take
longer
period
total
identif
process
malditof
ms
technic
revolut
microbi
field
faster
easier
techniqu
microbi
identif
pathogen
microorgan
apart
protein
extract
wholecel
bacteria
lysat
prepar
chemic
treatment
direct
bacteri
analysi
usual
adopt
bacteri
identif
malditof
ms
play
key
role
clinic
diagnost
prognost
workup
biofilm
format
control
protein
profil
obtain
singl
coloni
bacteria
directli
deposit
malditof
ms
target
plate
overlaid
matrix
solut
malditof
ms
use
identifi
microorgan
speci
level
also
subspeci
strain
level
also
identifi
bacteri
toxin
crutchfield
et
al
malditof
ms
rapid
easi
rel
inexpens
highthroughput
method
identifi
clinic
relev
bacteria
fungi
malditof
ms
method
implement
identifi
common
microorgan
cobo
van
belkum
et
al
character
pathogen
base
malditof
ms
fingerprint
profil
routin
diagnost
microbiolog
entir
process
complet
four
step
ie
detect
id
suscept
test
epidemiolog
malditof
ms
protein
fingerprint
employ
patternmatch
algorithm
compar
microbi
cell
extract
peak
list
refer
databas
henc
creat
consensu
biomark
peak
list
character
averag
mz
intens
malditof
ms
also
potenti
identifi
pathogen
direct
sampl
urin
blood
cultur
furthermor
potenti
id
serotyp
strain
level
antibiot
resist
profil
within
minut
make
malditof
ms
ongo
revolut
clinic
microbiolog
laboratori
emonet
et
al
suttisunhakul
et
al
proteom
play
key
role
develop
novel
therapeut
strategi
identif
vaccin
antibiot
target
antigen
protein
identifi
immun
respons
infect
protein
use
develop
vaccin
specif
protein
select
identifi
optim
vaccin
develop
order
develop
vaccin
bacteri
cell
treat
stress
bacteri
infect
condit
protein
analyz
electrophoresi
describ
newli
express
protein
support
bioinformat
approach
identif
vaccin
candid
protein
took
advantag
extens
gene
sequenc
data
avail
bilgic
et
al
drug
resist
pathogen
major
problem
recurr
infect
diseas
proteom
determin
antimicrobi
resist
mechan
analysi
microbi
protein
explain
drug
resist
develop
lead
improv
extend
efficaci
current
antimicrobi
li
et
al
pseudomona
aeruginosa
develop
resist
betalactam
antibiot
proteom
identifi
resist
mechan
reduc
express
outer
membran
protein
imipenem
ceftazidim
ampicillin
treatment
streptococcu
pneumonia
develop
resist
penicillin
erythromycin
also
two
phenotyp
pneumonia
specif
ml
phenotyp
proteom
investig
resist
mechan
phenotyp
resist
express
mefe
encod
membran
transport
protein
reduc
intracellular
level
erythromycin
ml
phenotyp
owe
resist
methyl
rrna
antibiot
action
investig
locat
protein
show
differenti
express
pattern
bacteria
grown
presenc
absenc
antibiot
data
give
deep
boost
develop
novel
therapeut
compound
editori
mini
focu
issu
system
biolog
li
et
al
wang
et
al
yari
et
al
proteom
made
import
impact
medic
biolog
provid
valuabl
data
relat
hostpathogen
interact
posttransl
modif
help
better
understand
microbi
commun
function
microbi
physiolog
pathogen
microbi
identif
character
difficult
autom
overcom
difficulti
malditof
compar
sequenc
help
therefor
maldotof
ms
becom
power
tool
routin
pathogen
identif
clinic
laboratori
malditof
bacteri
identif
sequenc
approach
timeconsum
costeffect
process
malditof
analysi
routin
microbiolog
laboratori
proteom
analyz
hostpathogen
resist
mechan
investig
base
data
proteom
may
serv
neither
primari
screen
method
antigen
detect
complementari
method
confirm
bioinformat
predict
immunogen
analysi
chiang
et
al
abil
rapidli
identifi
pathogen
specif
clinic
specimen
help
us
studi
clinic
burden
result
emerg
speci
human
pathogen
definit
suggest
malditof
ms
altern
molecular
method
clinic
laboratori
revolution
bacteri
identif
field
medic
microbiolog
come
futur
